Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

K
Kümler, Thomas

Department of Cardiology, Herlev University Hospital
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Thomas Kümler
Favorite
Kacena, Katherine

Strand Therapeutics Inc
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Katherine Kacena
Favorite
Kaczkofsky, Brynn

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Brynn Kaczkofsky
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Brynn Kaczkofsky
Favorite
Kaderi, Saif

Tata Memorial Hospital
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Saif Kaderi
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Saif Kaderi
Favorite
Kalbasi, Anusha

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Anusha Kalbasi
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Anusha Kalbasi
Favorite
Kalinowska, Iwona

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Iwona Kalinowska
Favorite
Kalisa, Aimé Terence

Department of Surgery, Medical Faculty Mannheim, Mannheim School of Medicine, Heidelberg University
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Aimé Terence Kalisa
Favorite
Kaloti, Ramneet

UHN
(P 465) JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TODRIVE CIC-REARRANGED SARCOMAS
Ramneet Kaloti
Favorite
Kaltoft, Nicolai Stefan

Dept. of Radiology, Rigshospitalet - Copenhagen University HospitalRigshospitalet, Copenhagen University Hospital
(P 322) DYNAMIC PET/MRI REVEALS METABOLIC-DIFFUSION INTERACTIONS IN SUSPECTED SOFT TISSUE SARCOMAS
Nicolai Stefan Kaltoft
Favorite
Kaluziak, Stefan

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Stefan Kaluziak
Favorite
Kalyan, Prinjali

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Prinjali Kalyan
Favorite
Kamal, Caroline

Memorial Healthcare System
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Caroline Kamal
Favorite
Kanarek, Naama

Children's Hospital Boston
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Naama Kanarek
Favorite
Kane, Kathleen

Bone Cancer Research Trust
(P 207) LONG-TERM FOLLOW-UP AND LATE EFECTS MONITORING FOR UK BONE SARCOMA PATIENTS: A SERVICE MAPPING EXCERCISE
Kathleen Kane
Favorite
Kaneko, Taryn

Stanford Medicine
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Taryn Kaneko
Favorite
Kang, Alina

University of Miami Miller School of Medicine
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Alina Kang
Favorite
Kang, Grace

University of Tennessee Health Science Center
(P 275) NEXT GENERATION SEQUENCING IN ADOLESCENT AND YOUNG ADULT (AYA) SARCOMAS: CLINICAL IMPACT, DIAGNOSTIC UTILITY, AND IMPLICATIONS
Grace Kang
Favorite
Kang, Hakmook

Vanderbilt University Medical Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Hakmook Kang
Favorite
Kang, Hyun Guy

National Cancer Center
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
Hyun Guy Kang
Favorite
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Hyun Guy Kang
Favorite
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Hyun Guy Kang
Favorite
Kang, Hyun-Cheol

Department of Radiation Oncology, Seoul National University Hospital
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Hyun-Cheol Kang
Favorite
Kao, Steven

Department of Medical Oncology, Chris O'Brien Lifehouse
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Steven Kao
Favorite
Karabajakian, Andy

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Andy Karabajakian
Favorite
Karadimas, Thomas

USF Health Morsani College of Medicine
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Thomas Karadimas
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Thomas Karadimas
Favorite
Kasenda, Benjamin

Universitätsspital Basel (USB)
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Benjamin Kasenda
Favorite
Kashyap, Saarang

Precision NextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Saarang Kashyap
Favorite
Kasper, Bernd

Mannheim University Medical Center, University of Heidelberg
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Bernd Kasper
Favorite
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Bernd Kasper
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Bernd Kasper
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Bernd Kasper
Favorite
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Bernd Kasper
Favorite
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Bernd Kasper
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Bernd Kasper
Favorite
(P 456) OUTCOMES OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ADULT-TYPE RHABDOMYOSARCOMAS: POOLED ANALYSIS OF CLINICAL TRIALS FROM THE EORTC SOFT TISSUE AND BONE SARCOMA GROUP
Bernd Kasper
Favorite
kasraoui, Ines

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Ines kasraoui
Favorite
Kassim, Yusra

Department of Medical Oncology, The Ottawa Hospital, Ottawa, ON, Canada.
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Yusra Kassim
Favorite
Kass, Jonathan

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Jonathan Kass
Favorite
Katagiri, Hirohisa

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Hirohisa Katagiri
Favorite
Kato, Shumei

University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Shumei Kato
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Shumei Kato
Favorite
Katwala, Ajay

Medical College of Wisconsin
(P 329) LAPAROSCOPY-ASSISTED PERCUTANEOUS CRYOABLATION FOR THE TREATMENT OF ABDOMINAL WALL DESMOID TUMORS
Ajay Katwala
Favorite
Katz, Daniela

Shaare Zedek Medical Center
(P 326) GERMLINE POT1 MUTATIONS IN ANGIOSARCOMA DIFFER FROM SOMATIC MUTATIONS
Daniela Katz
Favorite
Kawai, Akira

National Cancer Center Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Akira Kawai
Favorite
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Akira Kawai
Favorite
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Akira Kawai
Favorite
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Akira Kawai
Favorite
Kawamura, Miyuki

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Miyuki Kawamura
Favorite
Keedy, Vicki Leigh

Division of Hematology/Oncology, Vanderbilt University Medical Center
(P 310) ATYPICAL SPINDLE CELL PLEOMORPHIC LIPOMATOUS TUMORS OF THE RETROPERITONEUM ARE HETEROGENOUS: A REPORT OF FOUR DISPARATE CASES
Vicki Leigh Keedy
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Vicki Leigh Keedy
Favorite
Keen, Judy

Judy Keen Constulting
(P 209) SARCOMA PATIENT COMMUNITY DATA COLLABORATION TO ADVANCE RESEARCH
Judy Keen
Favorite
Keeter, Carson

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Carson Keeter
Favorite
Kelaney, Mohamed R

Ain Shams University
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Mohamed R Kelaney
Favorite
Kelly, Ciara

Sarcoma Medical Oncology Service, Memorial Sloan Kettering
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Ciara Kelly
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Ciara Kelly
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Ciara Kelly
Favorite
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
Ciara Kelly
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Ciara Kelly
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Ciara Kelly
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Ciara Kelly
Favorite
Kelly, Hillary

Massachusetts General Hospital and Massachusetts Eye and Ear
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Hillary Kelly
Favorite
Kendal, Joseph

University of Calgary
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Joseph Kendal
Favorite
Kenna, Emma

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Emma Kenna
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Emma Kenna
Favorite
Kenney, Deborah

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Deborah Kenney
Favorite
Kenney, Richard

Sonnet BioTherapeutics
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
Richard Kenney
Favorite
Keohan, Mary

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Mary Keohan
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Mary Keohan
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Mary Keohan
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Mary Keohan
Favorite
Kerfoot, Joseph

Dana-Farber Cancer Institute
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Joseph Kerfoot
Favorite
Kerimo, Emma Rose

Massachusetts General Hospital
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Emma Rose Kerimo
Favorite
Kerstein, David

IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
David Kerstein
Favorite
Keung, Emily

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Emily Keung
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Emily Keung
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Emily Keung
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Emily Keung
Favorite
Key, Brandon

Medical College of Wisconsin
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
Brandon Key
Favorite
(P 329) LAPAROSCOPY-ASSISTED PERCUTANEOUS CRYOABLATION FOR THE TREATMENT OF ABDOMINAL WALL DESMOID TUMORS
Brandon Key
Favorite
Khalil, Moustafa

Centre de recherche Maisonneuve-Rosemont
(P 46) INVESTIGATING THE IMPACT OF SARCOMA FUSION PROTEINS ON EPIGENETIC AND DNA-DEPENDENT PROCESSES THROUGH INTERACTOME PROFILING
Moustafa Khalil
Favorite
Khan, Faaris

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Faaris Khan
Favorite
Khanna, Nehal

Tata Memorial Hospital
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Nehal Khanna
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Nehal Khanna
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Nehal Khanna
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Nehal Khanna
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Nehal Khanna
Favorite
Khela, Monty

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Monty Khela
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Monty Khela
Favorite
Khosravi, Amirali

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Amirali Khosravi
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Amirali Khosravi
Favorite
Khosroyani, Homma

OHSU Knight Cancer Institute
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Homma Khosroyani
Favorite
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Homma Khosroyani
Favorite
Khushman, Moh’d

Washington University School of Medicine
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Moh’d Khushman
Favorite
Kichenadasse, Ganessan

Flinders Medical Centre
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Ganessan Kichenadasse
Favorite
Kilpatrick, Scott

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Scott Kilpatrick
Favorite
Kim, Angela

Yale School of Medicine
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Angela Kim
Favorite
Kim, Carl

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Carl Kim
Favorite
Kim, Edward

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Edward Kim
Favorite
Kim, Ha Jeong

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Ha Jeong Kim
Favorite
Kim, Hangil

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Hangil Kim
Favorite
Kim, Han-Soo

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Han-Soo Kim
Favorite
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
Han-Soo Kim
Favorite
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
Han-Soo Kim
Favorite
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Han-Soo Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Han-Soo Kim
Favorite
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Han-Soo Kim
Favorite
(P 399) LATE LOCAL RECURRENCE (>5YEARS) OF SOFT TISSUE SARCOMA OF THE EXTREMITIES AND TRUNK WALL: PREDICTIVE FACTORS AND ONCOLOGIC OUTCOMES
Han-Soo Kim
Favorite
Kim, Hayun

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Hayun Kim
Favorite
Kim, HyoSong

Yonsei University College of Medicine
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
HyoSong Kim
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
HyoSong Kim
Favorite
Kim, Jinhwan

Biomedical Engineering, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Jinhwan Kim
Favorite
Kim, June Hyuk

National Cancer Center
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
June Hyuk Kim
Favorite
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
June Hyuk Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
June Hyuk Kim
Favorite
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
June Hyuk Kim
Favorite
Kim, Minsu

Seoul National University
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Minsu Kim
Favorite
Kim, Shinn

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Shinn Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Shinn Kim
Favorite
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Shinn Kim
Favorite
Kim, So Young

Duke University Medical Center
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
So Young Kim
Favorite
Kim, Soon-Chan

Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Soon-Chan Kim
Favorite
Kimura, Toshimi

Department of Pharmacy, Juntendo University
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Toshimi Kimura
Favorite
Kim, Wanlim

Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Wanlim Kim
Favorite
Kim, Yongsung

Department of Orthopaedic surgery, Seoul National University Bundang Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Yongsung Kim
Favorite
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
Yongsung Kim
Favorite
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Yongsung Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Yongsung Kim
Favorite
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Yongsung Kim
Favorite
King, Bo

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Bo King
Favorite
King, David

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
David King
Favorite
Kirsch, David

Princess Margaret Cancer Centre
(P 43) OVERCOMING PROMISCUOUS TUMOR FORMATION: A CONTROLLED GENETICALLY ENGINEERED MOUSE MODEL OF CIC::DUX4 SARCOMA
David Kirsch
Favorite
(P 57) STUDYING HYPOXIA-INDUCED METASTASIS IN GENETICALLY ENGINEERED MOUSE MODELS OF UPS
David Kirsch
Favorite
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
David Kirsch
Favorite
(P 67) MULTIPLE MESENCHYMAL LINEAGES AS POTENTIAL CELL-OF-ORIGINS OF SMARCB1-DEFICIENT EPITHELIOID SARCOMA
David Kirsch
Favorite
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
David Kirsch
Favorite
Kirschstein, Josephine

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Josephine Kirschstein
Favorite
Kirsner, Robert

Jackson Memorial Hospital/University of Miami Health System
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Robert Kirsner
Favorite
Kisielewska, Katarzyna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 191) EFFICACY OF SYSTEMIC PALLIATIVE THERAPIES IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PREVIOUSLY TREATED WITH ADJUVANT IMATINIB - REAL-WORLD CLINICAL PRACTICE DATA
Katarzyna Kisielewska
Favorite
Kistner-Griffin, Emily

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Emily Kistner-Griffin
Favorite
Kitada, Tasuku

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Tasuku Kitada
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Tasuku Kitada
Favorite
Klauber-DeMore, Nancy

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Nancy Klauber-DeMore
Favorite
Klauschen, Frederick

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Frederick Klauschen
Favorite
Klega, Kelly

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Kelly Klega
Favorite
Klein Schwengber, Wallace

Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Wallace Klein Schwengber
Favorite
Klein, Alexander

Orthopaedic Oncology, Department of Orthopaedics and Trauma Surgery, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Alexander Klein
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Alexander Klein
Favorite
kleinman, Claudia

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Claudia kleinman
Favorite
Klempner, Samuel J.

Massachusetts General Hospital
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Samuel J. Klempner
Favorite
Klimczak, Anna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 191) EFFICACY OF SYSTEMIC PALLIATIVE THERAPIES IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PREVIOUSLY TREATED WITH ADJUVANT IMATINIB - REAL-WORLD CLINICAL PRACTICE DATA
Anna Klimczak
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Anna Klimczak
Favorite
Klinkhammer-Schalke, Monika

aBavarian Cancer Registry, Regional Center Würzburg, Bavarian Health and Food Safety Authority
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Monika Klinkhammer-Schalke
Favorite
Knösel, Thomas

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Thomas Knösel
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Thomas Knösel
Favorite
Kneser, Ulrich

Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, 67071 Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Ulrich Kneser
Favorite
Knops, Rutger

Princess Máxima Center for Pediatric Oncology
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Rutger Knops
Favorite
Kobald, Samantha

University of New England College of Osteopathic Medicine
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Samantha Kobald
Favorite
Kobayashi, Eisuke

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Eisuke Kobayashi
Favorite
Kochat, Veena

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Veena Kochat
Favorite
Koch, Keith

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Keith Koch
Favorite
Kojima, Yuki

Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Yuki Kojima
Favorite
Kollár, Attila

Department of Medical Oncology, University Hospital Bern, Inselspital
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Attila Kollár
Favorite
Kondo, Hiroya

Okayama University Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Hiroya Kondo
Favorite
Kondo, Hiroya

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Hiroya Kondo
Favorite
Kong, Chang-Bae

Korea Cancer Center Hospital
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Chang-Bae Kong
Favorite
Konieczkowski, David

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
David Konieczkowski
Favorite
Koo, Younghyun

Department of Artificial Intelligence and Data Science, Sejong University, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Younghyun Koo
Favorite
Kopec, Sylwia

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Sylwia Kopec
Favorite
Korah, Maria

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Maria Korah
Favorite
Korfhage, Justin

Yale University
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Justin Korfhage
Favorite
Koseła-Paterczyk, Hanna

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Hanna Koseła-Paterczyk
Favorite
Kosela-Paterczyk, Hanna

Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Hanna Kosela-Paterczyk
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Hanna Kosela-Paterczyk
Favorite
Ko, Somang

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Somang Ko
Favorite
Kotamraju, Tushar

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Tushar Kotamraju
Favorite
Kotzur, Travis

University of Texas San Antonio Health
(P 78) MENTAL HEALTH DISORDERS FOLLOWING PATHOLOGICAL FRACTURE: A RETROSPECTIVE COHORT STUDY
Travis Kotzur
Favorite
Kozak, Katarzyna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Katarzyna Kozak
Favorite
Kozak, Margaret

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Margaret Kozak
Favorite
Kozlek, Tom

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Tom Kozlek
Favorite
Krabbe, Ellen

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Ellen Krabbe
Favorite
Kram, David

University of North Carolina
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
David Kram
Favorite
Krarup-Hansen, Anders

Department of Oncology, Herlev University Hospital
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Anders Krarup-Hansen
Favorite
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Anders Krarup-Hansen
Favorite
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Anders Krarup-Hansen
Favorite
Krasniqi, Fatime

Department of Oncology, University Hospital Basel
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Fatime Krasniqi
Favorite
Krawetz, Roman

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Roman Krawetz
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Roman Krawetz
Favorite
Krishnamoorthy, Murali

Msas Eye and Ear
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Murali Krishnamoorthy
Favorite
Krishnan, Chandra Kumar

Cancer Institute (WIA), Adyar, Chennai
(P 110) DEFINITIVE RADIATION THERAPY IN "OPERABLE" EWING SARCOMA OF THE EXTREMITIES AND PELVIS
Chandra Kumar Krishnan
Favorite
Krishna, Sakshi

Vanderbilt University School of Medicine
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Sakshi Krishna
Favorite
Krotewicz, Maria

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Maria Krotewicz
Favorite
Kubik, William

McGill University
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
William Kubik
Favorite
Kucharik, Michael

University of South Florida
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Michael Kucharik
Favorite
Kuijjer, Marieke

Centre for Molecular Medicine Norway
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Marieke Kuijjer
Favorite
Ku, Ja-Lok

Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Ja-Lok Ku
Favorite
Kuleshov, Nikol

Service d'hémato-oncologie, CHU de Québec - Université Laval, Québec, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Nikol Kuleshov
Favorite
Kulkarni, Nichita

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Nichita Kulkarni
Favorite
Kumar, Anand

Harvard Medical School, Mass Eye and Ear
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Anand Kumar
Favorite
Kumar, Kiran

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Kiran Kumar
Favorite
Kumar, Sonia

Humanitas University
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Sonia Kumar
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Sonia Kumar
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Sonia Kumar
Favorite
Kumar, Surinder

University of Miami
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Surinder Kumar
Favorite
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Surinder Kumar
Favorite
Kummar, Shivaani

Oregon Health and Science University
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Shivaani Kummar
Favorite
Kung, Andrew

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Andrew Kung
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Andrew Kung
Favorite
(P 26) DEVELOPING AN ORTHOTOPIC MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Andrew Kung
Favorite
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Andrew Kung
Favorite
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Andrew Kung
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Andrew Kung
Favorite
Kunisada, Toshiyuki

Okayama University Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Toshiyuki Kunisada
Favorite
Kunning, Sheryl

UPMC Department of Immunology and Hillman Cancer Center
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Sheryl Kunning
Favorite
Kunz, Wolfgang G.

Department of Radiology, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Wolfgang G. Kunz
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Wolfgang G. Kunz
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Wolfgang G. Kunz
Favorite
Kuo, Fengshen

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Fengshen Kuo
Favorite
Kuttschreuter, Luke

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Luke Kuttschreuter
Favorite
Kwon, Daeheon

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Daeheon Kwon
Favorite
Kwon, Jee Young

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Jee Young Kwon
Favorite
Kwon, Sunghoon

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Sunghoon Kwon
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Sunghoon Kwon
Favorite